KAT6B
Overview
KAT6B (Lysine Acetyltransferase 6B) encodes a MYST-family histone acetyltransferase that acetylates histone H3 at lysine 9 and lysine 14. It forms part of the MOZ/MORF HAT complex and plays roles in developmental gene regulation. In cancer genomics, KAT6B is a recurrently mutated HAT-complex subunit in medulloblastoma.
Alterations observed in the corpus
Cancer types (linked)
- SHH medulloblastoma: HAT-complex subunit altered as part of a recurrent epigenetic driver class affecting 19% of SHH tumors PMID:28726821
Co-occurrence and mutual exclusivity
- Co-altered with other HAT-complex members (KANSL1, CREBBP, EP300, BRPF1) in SHH medulloblastoma PMID:28726821
Therapeutic relevance
- HAT-complex alterations in SHH medulloblastoma may sensitize to epigenetic therapeutic approaches, though no direct targeted therapy is established.
Open questions
- The relative contribution of KAT6B vs. other HAT-complex members to medulloblastoma pathogenesis remains unclear.
Sources
This page was processed by crosslinker on 2026-05-15.